Pui Yee Ng

Person

Boston, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
- Patent number 12,304,904
- Issue date May 20, 2025
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 12,264,137
- Issue date Apr 1, 2025
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors
- Patent number 12,213,969
- Issue date Feb 4, 2025
- Valo Health, Inc.
- Xiaozhang Zheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carboxamides as ubiquitin-specific protease inhibitors
- Patent number 12,162,888
- Issue date Dec 10, 2024
- Valo Health, Inc.
- David J. Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
- Patent number 11,919,839
- Issue date Mar 5, 2024
- Valo Health, Inc.
- Kenneth W. Bair
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 11,891,365
- Issue date Feb 6, 2024
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors
- Patent number 11,730,721
- Issue date Aug 22, 2023
- Valo Health, Inc.
- Xiaozhang Zheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
- Patent number 11,702,412
- Issue date Jul 18, 2023
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoindolines as HDAC inhibitors
- Patent number 11,535,607
- Issue date Dec 27, 2022
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Carboxamides as ubiquitin-specific protease inhibitors
- Patent number 11,524,966
- Issue date Dec 13, 2022
- Valo Health, Inc.
- David J. Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
[6,6] fused bicyclic HDAC8 inhibitors
- Patent number 11,414,392
- Issue date Aug 16, 2022
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods using HDAC11 inhibitors
- Patent number 11,345,672
- Issue date May 31, 2022
- Valo Health, Inc.
- Jennifer Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
- Patent number 11,325,917
- Issue date May 10, 2022
- Valo Health, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 11,279,681
- Issue date Mar 22, 2022
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 11,274,084
- Issue date Mar 15, 2022
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 11,274,085
- Issue date Mar 15, 2022
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,988,450
- Issue date Apr 27, 2021
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
- Patent number 10,988,441
- Issue date Apr 27, 2021
- Valo Early Discovery, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors
- Patent number 10,913,753
- Issue date Feb 9, 2021
- Valo Early Discovery, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
- Patent number 10,889,592
- Issue date Jan 12, 2021
- Valo Early Discovery, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors
- Patent number 10,874,649
- Issue date Dec 29, 2020
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,870,645
- Issue date Dec 22, 2020
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
[6,6] fused bicyclic HDAC8 inhibitors
- Patent number 10,829,460
- Issue date Nov 10, 2020
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,829,461
- Issue date Nov 10, 2020
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,829,462
- Issue date Nov 10, 2020
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,822,316
- Issue date Nov 3, 2020
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted bridged urea analogs as sirtuin modulators
- Patent number 10,590,135
- Issue date Mar 17, 2020
- GlaxoSmithKline LLC
- Charles A. Blum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors
- Patent number 10,555,935
- Issue date Feb 11, 2020
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods using HDAC11 inhibitors
- Patent number 10,538,496
- Issue date Jan 21, 2020
- Forma Therapeutics, Inc.
- Jennifer Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
- Patent number 10,513,501
- Issue date Dec 24, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PYRIDINYLOXYPYRIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATI...
- Publication number 20250228835
- Publication date Jul 17, 2025
- Rectify Pharmaceuticals, Inc.
- Nathan Oliver Fuller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
6-AZA-QUINOLINE DERIVATIVES AND RELATED USES
- Publication number 20250017914
- Publication date Jan 16, 2025
- Black Diamond Therapeutics, Inc.
- Pui Yee NG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
6-SUBSTITUTED-9H-PURINE DERIVATIVES AND RELATED USES
- Publication number 20240317752
- Publication date Sep 26, 2024
- Black Diamond Therapeutics, Inc.
- Pui Yee NG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-SPIRO-5- AND 6-HYDROXAMIC ACID INDANES AS HDAC INHIBITORS
- Publication number 20230414585
- Publication date Dec 28, 2023
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
[6,6] FUSED BICYCLIC HDAC8 INHIBITORS
- Publication number 20230406830
- Publication date Dec 21, 2023
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC [4,6,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20230357216
- Publication date Nov 9, 2023
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINES AS HDAC INHIBITORS
- Publication number 20230242512
- Publication date Aug 3, 2023
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20220363651
- Publication date Nov 17, 2022
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS USING HDAC11 INHIBITORS
- Publication number 20220235018
- Publication date Jul 28, 2022
- Valo Health, Inc.
- Jennifer Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20220204461
- Publication date Jun 30, 2022
- Valo Health, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS
- Publication number 20220073452
- Publication date Mar 10, 2022
- Valo Early Discovery, Inc.
- Kenneth W. Bair
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
- Publication number 20210323975
- Publication date Oct 21, 2021
- Valo Early Discovery, Inc.
- David J. GUERIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOINDOLINES AS HDAC INHIBITORS
- Publication number 20210253555
- Publication date Aug 19, 2021
- Valo Early Discovery, Inc.
- Xiaozhang ZHENG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC [4,6,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20210206755
- Publication date Jul 8, 2021
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-SPIRO-5- AND 6-HYDROXAMIC ACID INDANES AS HDAC INHIBITORS
- Publication number 20210186940
- Publication date Jun 24, 2021
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
[6,6] FUSED BICYCLIC HDAC8 INHIBITORS
- Publication number 20210139439
- Publication date May 13, 2021
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS
- Publication number 20210047343
- Publication date Feb 18, 2021
- Valo Early Discovery, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ALKYL BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20210009539
- Publication date Jan 14, 2021
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20210009538
- Publication date Jan 14, 2021
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20210009540
- Publication date Jan 14, 2021
- Valo Early Discovery, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS
- Publication number 20200331847
- Publication date Oct 22, 2020
- Forma Therapeutics, Inc.
- Kenneth W. Bair
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-SPIRO-5- AND 6-HYDROXAMIC ACID INDANES AS HDAC INHIBITORS
- Publication number 20200121655
- Publication date Apr 23, 2020
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS USING HDAC11 INHIBITORS
- Publication number 20200079744
- Publication date Mar 12, 2020
- Forma Therapeutics, Inc.
- Jennifer Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3-ALKYL BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20200055830
- Publication date Feb 20, 2020
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20200048211
- Publication date Feb 13, 2020
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ARYL-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20200048212
- Publication date Feb 13, 2020
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thienopyridine Carboxamides as Ubiquitin-Specific Protease Inhibitors
- Publication number 20200017525
- Publication date Jan 16, 2020
- Forma Therapeutics, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20200002298
- Publication date Jan 2, 2020
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors
- Publication number 20190359628
- Publication date Nov 28, 2019
- Forma Therapeutics, Inc.
- David Joseph Guerin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC [4,6,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
- Publication number 20190345149
- Publication date Nov 14, 2019
- Forma Therapeutics, Inc.
- Xiaozhang Zheng
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

Carboxamides as ubiquitin-specific protease inhibitors

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

Isoindolines as HDAC inhibitors

Carboxamides as ubiquitin-specific protease inhibitors

[6,6] fused bicyclic HDAC8 inhibitors

Methods using HDAC11 inhibitors

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

Thienopyridine carboxamides as ubiquitin-specific protease inhibitors

Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

[6,6] fused bicyclic HDAC8 inhibitors

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Substituted bridged urea analogs as sirtuin modulators

2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors

Methods using HDAC11 inhibitors

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Patents Applicationslast 30 patents

PYRIDINYLOXYPYRIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATI...

6-AZA-QUINOLINE DERIVATIVES AND RELATED USES

6-SUBSTITUTED-9H-PURINE DERIVATIVES AND RELATED USES

2-SPIRO-5- AND 6-HYDROXAMIC ACID INDANES AS HDAC INHIBITORS

[6,6] FUSED BICYCLIC HDAC8 INHIBITORS

BICYCLIC [4,6,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

ISOINDOLINES AS HDAC INHIBITORS

3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

METHODS USING HDAC11 INHIBITORS

3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS

CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

ISOINDOLINES AS HDAC INHIBITORS

BICYCLIC [4,6,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

2-SPIRO-5- AND 6-HYDROXAMIC ACID INDANES AS HDAC INHIBITORS

[6,6] FUSED BICYCLIC HDAC8 INHIBITORS

THIENOPYRAZINE CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

3-ALKYL BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS

2-SPIRO-5- AND 6-HYDROXAMIC ACID INDANES AS HDAC INHIBITORS

METHODS USING HDAC11 INHIBITORS

3-ALKYL BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

3-ARYL-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

Thienopyridine Carboxamides as Ubiquitin-Specific Protease Inhibitors

3-ALKYL-4-AMIDO-BICYCLIC [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS

Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors

BICYCLIC [4,6,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS